{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-029482","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2025-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.112835+00:00","generated_at":"2026-05-16T11:57:50.139816+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"ENvue Medical amends 2024 Long Term Incentive Plan for Israeli tax compliance and name change","bullets":["Board approved amended and restated 2024 Long Term Incentive Plan on December 24, 2025.","Adds restricted stock units under Section 102 for Israeli tax compliance; other non-material updates.","Reflects company name change from NanoVibronix to ENvue Medical and prior stockholder-approved amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-029482","json":"https://secwatch.observer/filing/0001493152-25-029482.json","markdown":"https://secwatch.observer/filing/0001493152-25-029482.md","text":"https://secwatch.observer/filing/0001493152-25-029482.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225029482/0001493152-25-029482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225029482/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:57:50.139816+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}